Erratum (DOI:10.1016/j.transproceed.2009.02.042);Protective Effects of Heparin on Hepatic Ischemia and Reperfusion Lesions in Rabbits

Transplantation Proceedings

Volumn 41, Issue 3, 2009, Pages 812-815

  Taha, M O ^a   Goncalves P F Z R A ^b   Vidigal, R O G ^b   Sacchi, G P S ^b   Pinheiro, F G ^b   Brandao L S G ^b   Feguri, S ^b   Moraes Filho, A M ^b   Ghadie, M M ^a   Magalhaes K G ^a   Simoes M J ^a   Tersariol, I L S ^c   Monteiro, H P ^a   Oliveira Jr , I ^a   Jurkiewicz, A ^a   Caricati Neto, A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

^c UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPARIN; LACTATE DEHYDROGENASE; SODIUM CHLORIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; HEPATIC ARTERY; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER ISCHEMIA; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

EID: 64349122000     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.04.004     Document Type: Erratum

References (17)

1. Zhang Y.Y., Wang X.Y., Wang X.R., et al. Protective effect of flavonoids from Scutellaria baicalensis Georgi on cerebral ischemia injury. J Ethnopharmacol 108 (2006) 355
2. Culmsee C., and Krieglstein J. Emerging pharmacotherapeutic strategies for the treatment of ischemic stroke. Drug Discov Today Ther Strat 3 (2006) 621
3. Longa E.Z., Weinstain P.R., Carlson S., et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84
4. Grynkiewicz G., Poenie M., and Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (1985) 3440
5. Love S. Oxidative stress in brain ischemia. Brain Pathol 9 (1999) 119
6. White B.C., Sullivan J.M., DeGracia D.J., et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179 (2000) 1
7. Margaill I., Plotkine M., and Lerouet D. Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39 (2005) 429
8. Fuh K.C., Meneshian A., Patel C.B., et al. Signal transduction by reactive oxygen species: alternative paradigms for signaling specificity. Surgery 131 (2002) 601
9. Durukan A., and Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87 (2007) 179
10. Samama M.M., Desnoyers P.C., Conard J., et al. Acute ischemic stroke and heparin treatments. Thromb Haemost 78 (1997) 173
11. Kay R., Wong K.S., Yu Y.L., et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333 (1995) 1588
12. The FISS bis Investigators Group. Fraxiparine in ischemic Stroke Study (FISS bis). Cerebrovasc Dis 8 4 (1998) 19
13. He S.Q., Zhang Y.H., Venugopal S.K., et al. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl 12 (2006) 1869
14. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 279 (1998) 1265
15. Berge E., and Sandset P.M. Heparin in Acute Embolic Stroke Trial (HAEST). Cerebrovasc Dis S1 (1999) 127
16. Diener H.C., Ringelstein E.B., von Kummer R., et al. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Stroke 32 (2001) 22
17. Bath P.M., Lindenstrom E., and Boysen G. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 358 (2001) 702